Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Chondrosarcoma × Metformin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gastrointestinal 1 CNS 1

Conditions

Polycystic Ovary Syndrome 135 Breast Neoplasms 31 Prostatic Neoplasms 29 Insulin Resistance 27 Obesity 18 Pancreatic Neoplasms 13 Endometrial Neoplasms 12 Carcinoma, Non-Small-Cell Lung 12 Neoplasms 11 Infertility 11 Colorectal Neoplasms 11 Anovulation 9 Lung Neoplasms 8 Metabolic Syndrome 7 Melanoma 7 Hyperandrogenism 7 Glioblastoma 7 Diabetes Mellitus 7 Squamous Cell Carcinoma of Head and Neck 6 Neoplasm Metastasis 6 Rectal Neoplasms 5 Adenocarcinoma 5 Weight Loss 4 Urinary Bladder Neoplasms 4 Lymphoma, Large B-Cell, Diffuse 4 Head and Neck Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Adenocarcinoma of Lung 4 Uterine Cervical Neoplasms 3 Recurrence 3

Interventions

Filgrastim 4 Proton Therapy 3 Docetaxel 3 regorafenib 2 Sunitinib 2 Ifosfamide 2 Gemcitabine 2 Carboplatin 2 temsirolimus 1 pegfilgrastim 1 liposomal doxorubicin 1 lentiviral minigene vaccine of COVID-19 coronavirus 1 ivosidenib 1 itacitinib 1 etoposide phosphate 1 capivasertib 1 baricitinib 1 apatinib 1 angiotensin I (1-7) 1 abemaciclib 1 Zoledronic Acid 1 Weight-Bearing 1 Trabectedin 1 Topotecan 1 Thiotepa 1 Thalidomide 1 Taxes 1 TQ-B3525 1 Surveys and Questionnaires 1 Standard of Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02496741 2020-01-09

MACIST

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 1/2 Completed

CNSGastrointestinalSarcoma

Chondrosarcoma, Glioma, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡